top of page
Medical Checkup

INCYTE

Trial Enrolment Status

CLOSED

Disease Under Study

ASTHMA

Duration

~28 Weeks

About the Trial

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

Mechanism of Action:

JAK1 Inhibitor

Duration of Study

~28 Weeks

Phase

2

Principal Investigator

Dr. George Philteos

Sub-Investigator

Dr. Anushya Chelvanathan

Study Coordinator

Nusrat Jahan

Dr. Philteos and Associates | Dynamic Drug Advancement Limited

Address:

Hours:

601 Harwood Avenue South, Suite 201

Ajax, Ontario L1S 2J5

M-F:

9:00am - 5:00pm

Closed on statutory holidays

Main Office Phone: 

 

 

Main Office Fax:   

Clinical Trial Phone:

Clinical Trial Fax: 

Dr. Philteos: (905) 427-1419

Dr. Chelvanathan: (905) 239 0225

Dr. O'Loghlen: (905) 239 0221

(905) 427-0346

(365) 885-9086

(905) 239-2399

©2022 by Dynamic Drug Advancement. Proudly created with Wix.com

bottom of page